AIRP | PKD Patients' Association

55 Items

All Items

  • The neglected dimensions of ADPKD beyond CKD: psychological distress, body image, and early malnutrition towards a new psychological-nutritional paradigm

    Sara Farinone, Matteo Brambilla Pisoni, Pierpaolo Bianca, Michele Paolisi, Kristiana Kola, Paola Maiucchi, Micaela Petrone, Valentina Di Mattei, Giuseppe Vezzoli, Maria Teresa Sciarrone Alibrandi
    72-77
    DOI: https://doi.org/10.33393/gcnd.2026.3780
  • Beyond renal function: malnutrition and sarcopenia in ADPKD

    Matteo Brambilla Pisoni, Rodolfo Fernando Rivera, Martina Catania, Liliana Italia De Rosa, Kristiana Kola, Michele Paolisi, Pierpaolo Bianca, Sara Farinone, Micaela Petrone, Paola Maiucchi, Lorena Citterio, Chiara Livia Lanzani, Paolo Manunta, Giuseppe Vezzoli, Maria Teresa Sciarrone Alibrandi
    63-71
    DOI: https://doi.org/10.33393/gcnd.2026.3752
  • Our commitment to research, awareness, and active participation

    Luisa Sternfeld Pavia
    59
    DOI: https://doi.org/10.33393/gcnd.2026.3809
  • Valeria writes…

    Luisa Sternfeld Pavia
    60-62
    DOI: https://doi.org/10.33393/gcnd.2026.3779
  • ADPKD: Tolvaptan and new therapeutic directions

    Vicente E. Torres
    14-16
    DOI: https://doi.org/10.33393/gcnd.2025.3743
  • Autosomal Dominant Polycystic Kidney Disease in 2025: One disease or many?

    Albert Ong
    7-10
    DOI: https://doi.org/10.33393/gcnd.2025.3741
  • Twenty years of AIRP: two decades of promoting knowledge, care, and research in the field of polycystic kidney disease

    Francesco Scolari
    2
    DOI: https://doi.org/10.33393/gcnd.2025.3784
  • Polycystic liver disease (PLD) associated with autosomal dominant polycystic kidney disease (ADPKD): from pathogenesis to transplantation

    Irene Capelli, Sarah Lerario, Valeria Aiello, Francesca Ciurli, Matteo Ravaioli, Gaetano La Manna
    31-32
    DOI: https://doi.org/10.33393/gcnd.2025.3750
  • Hemodialysis or peritoneal dialysis?

    Carmelita Marcantoni, Rosa Giunta
    27-28
    DOI: https://doi.org/10.33393/gcnd.2025.3748
  • Chronic renal disease in children with Autosomal Recessive Polycystic Kidney Disease

    Laura Massella
    21-23
    DOI: https://doi.org/10.33393/gcnd.2025.3746
  • Metformin and nephroprotection in Autosomal Dominant Polycystic Kidney Disease: preclinical evidence and preliminary results from the METROPOLIS trial

    Giovanni Piscopo
    17-18
    DOI: https://doi.org/10.33393/gcnd.2025.3744
  • ADPKD – Genetic Testing: Clinical Utility and Diagnostic Utility

    Claudia Izzi, Valeria Cinquina, Roberta Cortinovis
    11-13
    DOI: https://doi.org/10.33393/gcnd.2025.3742
  • Opening lecture. 20 years of progress in polycystic kidney disease research

    Alessandra Boletta
    3-6
    DOI: https://doi.org/10.33393/gcnd.2025.3740
  • Twenty years of commitment: a growing community, advancing research

    Luisa Sternfeld Pavia
    1
    DOI: https://doi.org/10.33393/gcnd.2025.3783
  • Living with polycystic kidney disease: psychological aspects in the care journey

    Sara Farinone, Martina Catania, Liliana Italia De Rosa, Kristiana Kola, Pierpaolo Bianca, Michele Paolisi, Matteo Brambilla Pisoni, Paola Maiucchi, Micaela Petrone, Valentina Elisabetta Di Mattei, Paolo Manunta, Giuseppe Vezzoli, Chiara Lanzani, Maria Teresa Sciarrone Alibrandi
    33-34
    DOI: https://doi.org/10.33393/gcnd.2025.3751
  • ADPKD: Cerebral Aneurysms

    Laura Econimo
    29-30
    DOI: https://doi.org/10.33393/gcnd.2025.3749
  • Autosomal Dominant (ADPKD) and Autosomal Recessive (ARPKD) Polycystic Kidney Disease in young adults

    Antonio Mastrangelo
    24-26
    DOI: https://doi.org/10.33393/gcnd.2025.3747
  • ARPKD: molecular basis and perspectives on drug development

    Max C. Liebau
    19-20
    DOI: https://doi.org/10.33393/gcnd.2025.3745
  • A special year, an even brighter future

    Luisa Sternfeld
    64
    DOI: https://doi.org/10.33393/gcnd.2025.3678
  • Letter to AIRP: 20 years of commitment, a milestone to celebrate

    Marco Lombardi
    65
    DOI: https://doi.org/10.33393/gcnd.2025.3673
  • SGLT2 inhibitors in polycystic kidney disease (PKD): current evidence and future perspectives

    Marco Lombardi, Andrea Batazzi, Bernardo Martini, Alma Mehmetaj, Stefano Michelassi
    67-70
    DOI: https://doi.org/10.33393/gcnd.2025.3674
  • Act II – And meanwhile it grows clearer

    Luisa Sternfeld
    66
    DOI: https://doi.org/10.33393/gcnd.2025.3672
  • Prevention of Herpes Zoster in Chronic Kidney Disease

    Barbara Maresca, Giulia Conforti, Silvana Chicca, Marco Galliani
    23-26
    DOI: https://doi.org/10.33393/gcnd.2025.3548
  • A journey of hope: the power of a father’s love

    Luisa Sternfeld Pavia
    20-21
    DOI: https://doi.org/10.33393/gcnd.2025.3546
  • AIRP: 20 Years of Commitment in the Fight Against Polycystic Kidney Disease

    Luisa Sternfeld Pavia
    17
    DOI: https://doi.org/10.33393/gcnd.2025.3544
1-25 of 55